Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06957548

Cardiometabolic Disease Risk Factors in Cameroon

Screening for Cardiometabolic Disease Risk Factors: a Community Health Screening Program in Urban Cameroon

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Cardiometabolic diseases (CMDs) are a major public health concern in sub-Saharan Africa, including Cameroon. Studies have shown a significant increase in the prevalence of hypertension, diabetes, and obesity in recent years. However, access to timely diagnosis and treatment remains limited, particularly in rural areas. Community-based screening programs have been shown to be effective in identifying individuals with undiagnosed CMD risk factors and promoting early intervention. By leveraging the strengths of community-based approaches, the URBACAM-D study aims to address the growing burden of CMDs in urban Cameroon.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiometabolic diseaseCardiometabolic disease screening

Timeline

Start date
2025-07-09
Primary completion
2025-10-12
Completion
2027-02-12
First posted
2025-05-04
Last updated
2025-11-26

Locations

1 site across 1 country: Cameroon

Source: ClinicalTrials.gov record NCT06957548. Inclusion in this directory is not an endorsement.